Director Tomer Cohen of Oscar Health, Inc. reported the acquisition of 3,565 restricted stock units in a statement of changes in beneficial ownership filed on November 17, 2026, covering a transaction dated November 13, 2026.

Key Highlights

  • Reporting person: Tomer Cohen, identified as a Director of Oscar Health, Inc.
  • Security acquired: 3,565 restricted stock units (RSUs) of Class A Common Stock, acquired at a price of $0.
  • Transaction date: November 13, 2026, with the filing submitted November 17, 2026.
  • Post-transaction ownership: Cohen holds 3,565 shares of Class A Common Stock directly following the reported transaction.
  • Vesting schedule: RSUs vest on the earlier of the one-year anniversary of the grant date or the date of the next annual stockholders meeting, subject to continued service.
  • Settlement terms: Upon vesting, RSUs settle in Class A Common Stock on the earliest of the six-month anniversary of separation from service, death, disability, or within five days of a change in control.

Tomer Cohen's RSU Award at Oscar Health

Oscar Health, Inc. (NYSE:OSCR), a health insurance company, was the subject of a beneficial ownership report filed by Director Tomer Cohen on November 17, 2026. According to the filing, Cohen acquired 3,565 RSUs of Class A Common Stock on November 13, 2026, at a price of $0, in a transaction coded "A" (acquisition).

The filing states that each RSU represents a contingent right to receive one share of Oscar Health's Class A Common Stock. The RSUs are subject to a vesting condition tied to continued service, with vesting occurring on the earlier of the one-year anniversary of the grant date or the date of the next annual stockholders meeting of the issuer following the grant date. Settlement of vested RSUs will occur in Class A Common Stock on the earliest of the six-month anniversary of the director's separation from service, death or disability, or within five days following a change in control of the issuer, as the filing describes.

Following the reported transaction, Cohen's direct beneficial ownership in Oscar Health Class A Common Stock stands at 3,565 shares, as reported in the filing. No derivative securities were reported in Table II. The form was signed by Melissa Curtin as Attorney-in-Fact on November 17, 2026.

What Was Disclosed

Oscar Health Director Tomer Cohen reported the acquisition of 3,565 RSUs of Class A Common Stock on November 13, 2026, at no cost, with vesting tied to continued service and settlement in stock upon specified triggering events, as disclosed in a beneficial ownership statement filed November 17, 2026.